Last Update:
January 26, 2015
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader
Journal Papers, Abstracts, and
Commentaries
|
| |
The association of adiposity with kidney
function decline among HIV-infected adults: findings from
the Fat Redistribution and Metabolic Changes in HIV
Infection (FRAM) study.
Malkina A, Scherzer R, Shlipak M, et al
HIV Med. 2014 Sep
23.
Abstract
An update on the pharmacological strategies
in the treatment of HIV-1-associated adipose
redistribution syndromes.
Mateo MG, Gutierrez MD, Vidal F, Domingo P.
Expert Opin Pharmacother.
2014 Jun 16:1-12.
Abstract
Assessment of body fat composition disturbances by
bioimpedance analysis in
HIV-infected adults.
Freitas P, Carvalho D, Sa
Abstract
Reduced Kidney Function and Preclinical Atherosclerosis in
HIV-Infected Individuals:
The Study of Fat Redistribution and Metabolic Change in HIV
Infection (FRAM).
Jotwani V, Scherzer R, Choi A, Szczech L,
Am
J Nephrol. 2011 Apr 21;33(5):453-460.
Abstract
Open Neck Lipectomy for Patients with HIV-Related
Cervical Lipohypertrophy.
Ion L, Raveendran SS.
Aesthetic Plast Surg.
2011 Apr
1.
Abstract
Contribution of Inflammation to Fat Redistribution and Metabolic
Disturbances in HIV-1
Infected Patients.
Stankov MV, Behrens GM.
Curr Pharm
Des. 2010 Aug 5.
Abstract |
Disorders of Body Fat Distribution in
HIV-1-Infected Patients.
Moreno S, Miralles C, Negredo E,
et al
AIDS Rev.
2009 Jul-Sep;11(3):126-34
Abstract |
Fat distribution and longitudinal anthropometric changes in
HIV-infected men with and without
clinical evidence of lipodystrophy and HIV-uninfected controls: A
substudy of the Multicenter
AIDS Cohort Study.
Brown TT, Xu X, John M,
et al
AIDS Res Ther.
2009 May 13;6(1
Abstract |
A Prospective Study of Body Fat Redistribution, Lipid, and Glucose
Parameters in HIV-Infected Patients
Initiating Combination Antiretroviral Therapy.
Walmsley S, Cheung AM, Fantus G, et al
HIV Clin Trials. 2008 Sep-Oct;9(5):314-23.
Abstract
|
Prediction of Coronary Heart Disease Risk in HIV-Infected
Patients with Fat
Redistribution.
Hadigan C, Meigs JB, Wilson PW, et al
Clin Infect Dis 2003 Apr 1;36(7):909-16
Abstract
Fat distribution evaluated by computed tomography and metabolic abnormalities
in
patients
undergoing antiretroviral therapy: preliminary results of the LIPOCO study.
Saint-Marc T, Partisani M, Poizot-Martin I, et al.
AIDS 2000 Jan 7;14(1):37-49
Abstract
The fat redistribution syndrome in patients infected with HIV: measurements
of
body
shape
abnormalities.
Gerrior J, Kantaros J, Coakley E, et al.
J Am Diet Assoc 2001
Oct;101(10):1175-80
Abstract
Altered fat distribution in
HIV-positive men on nucleoside analog reverse
transcriptase inhibitor therapy.
Mulligan K, Tai VW, Algren H, et al.
J Acquir Immune Defic Syndr 2001 Apr 15;26(5):443-8
Abstract
The evaluation of metabolic function and fat redistribution in clinical trials.
(No authors listed)
HIV Med 2002 Jan;3(1):65-72
Abstract |
|
Conference
Reports, Abstracts, and Posters
| |
A prospective
study of body fat redistribution, lipid and glucose abnormalities in HIV
infected
patients initiating a protease inhibitor based HAART
SL Walmsley, A Foster, A M Cheung
(15IAC)
Abstract |
|
|
|
General/Miscellaneous
Reports
Facial
Lipoatrophy